NHS National Framework for the supply of Tocilizumab Injection
NHS England is establishing a national framework for supply of Tocilizumab Injection, a biologic medication used in rheumatology and other conditions. The framework runs from March 2026 to August 2027 with optional extensions up to 24 months.
- Closed5 November 2025
- Value£188m
- BuyerNHS England
- CategoryHealth & medical
- RegionUK-wide
You'll want to look if you're a pharmaceutical manufacturer or wholesaler licensed to supply biologic injections to the NHS
Might not suit a small firm
- the contract itself is a large one
- it needs coverage across the whole UK